Infections due to the fungus Cryptococcus neoformans have emerged as a major cause of morbidity and mortality in patients with impaired cell- mediated immunity (CMI), especially those with AIDS. This proposal focuses on defining specific and unique aspects of how lymphocytes contribute to host defenses against cryptococcosis.
specific aims i nclude: (1) Defining the lymphocyte populations in human blood capable of inhibiting growth of C. neoformans. Preliminary data demonstrate that freshly isolated and Interleukin (IL)-2-activated human NK cells and T cells are capable of directly attaching to an inhibiting the growth of C. neoformans. Important aspects of this interaction between lymphocytes and C. neoformans will be defined, including: (i) the exact phenotypes of the lymphocytes involved; (ii) the opsonic requirements; (iii) the ability of cytokines other than IL-2 to activate lymphocyte-mediated fungistasis; and (iv) the mechanism(s) by which lymphocytes mediate fungistasis. Both freshly isolated an cloned lymphocyte populations will be used. (2) Characterizing the nature of lymphocyte-C. neoformans intracellular conjugates. Preliminary data demonstrate both NK cells and T cells readily form conjugates with C. neoformans. Flow cytometry, videomicroscopy, and confocal scanning laser microscopy will be used to characterize the conditions under which conjugate formation occurs, the phenotypes of the lymphocytes forming conjugates, and the lymphocytic receptor(s) and fungal ligand(s) responsible for this interaction. (3) Investigating lymphocyte activation, cytokine gene expression and release following cryptococcal stimulation. Using fluorescent digital imaging microscopy and flow cytometry, intracellular calcium fluxes in individual lymphocytes will be determined as the cells attach to and spread over C. neoformans. Lymphocyte degranulation in response to cryptococcal stimulation will be determined by microscopic observation under Nomarski optics, and by measuring the release of BLT-esterase. Cytokine (IL-2, IL-4, interferon-gamma) gene expression and release by lymphocytes following direct and indirect cryptococcal stimulation will be determined. (4) Defining the conditions under which lymphoproliferation occurs in response to C. neoformans. Preliminary data demonstrate that naive donors have a weak lymphoproliferative response to whole C. neoformans unless the organisms are opsonized, and fail to respond to all to a panel of purified cryptococcal antigens. the specific opsonic requirements for lymphoproliferation will be determined in both naive subjects and patients who have recovered from cryptococcosis. In addition, the ability of patients to respond to purified cryptococcal antigens will be defined. Cytokine gene expression and release during the course of the lymphoproliferative response will be determined. Completion of these studies over the next five years should contribute important new information to our basic understanding of the immunology of cryptococcosis and may provide a rational basis for novel preventive and immunotherapeutic approaches to combating cryptococcosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
7R01AI025780-11
Application #
2517188
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1987-09-30
Project End
1998-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Ketelut-Carneiro, Natália; Ghosh, Sreya; Levitz, Stuart M et al. (2018) A Dectin-1-Caspase-8 Pathway Licenses Canonical Caspase-1 Inflammasome Activation and Interleukin-1? Release in Response to a Pathogenic Fungus. J Infect Dis 217:329-339
Deepe Jr, George S; Buesing, William R; Ostroff, Gary R et al. (2018) Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice. Vaccine 36:3359-3367
Upadhya, Rajendra; Baker, Lorina G; Lam, Woei C et al. (2018) Cryptococcus neoformans Cda1 and Its Chitin Deacetylase Activity Are Required for Fungal Pathogenesis. MBio 9:
Levitz, Stuart M (2017) Aspergillus vaccines: Hardly worth studying or worthy of hard study? Med Mycol 55:103-108
Tsyrkunou, Artsiom; Agarwal, Sarika; Koirala, Bibek et al. (2017) Properdin Levels in Individuals with Chemotherapy-Induced Neutropenia. Open Forum Infect Dis 4:ofw250
Specht, Charles A; Lee, Chrono K; Huang, Haibin et al. (2017) Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species. MBio 8:
Upadhya, Rajendra; Lam, Woei C; Maybruck, Brian et al. (2016) Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans. MBio 7:
Loures, Flávio V; Levitz, Stuart M (2015) XTT Assay of Antifungal Activity. Bio Protoc 5:
Loures, Flávio V; Röhm, Marc; Lee, Chrono K et al. (2015) Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps. PLoS Pathog 11:e1004643
Levitz, Stuart M; Huang, Haibin; Ostroff, Gary R et al. (2015) Exploiting fungal cell wall components in vaccines. Semin Immunopathol 37:199-207

Showing the most recent 10 out of 107 publications